What is Dr Aharonov?
Dr Aharonov operates as a premier medical practice dedicated to the intersection of facial plastic surgery and cosmetic rejuvenation. Under the leadership of a Double Board Certified surgeon, the firm provides a comprehensive suite of surgical and non-surgical interventions, including rhinoplasty, eyelid surgery, and advanced filler treatments. The practice distinguishes itself through a commitment to natural, balanced aesthetic outcomes, utilizing a patient-centric model that prioritizes meticulous surgical precision and personalized care plans. As a leader in the field, the company serves a discerning clientele seeking high-end facial enhancement, maintaining a reputation for excellence in both technical execution and patient satisfaction.
How much funding has Dr Aharonov raised?
Dr Aharonov has raised a total of $220K across 2 funding rounds:
Debt
$150K
Debt
$70K
Debt (2020): $150K with participation from PPP
Debt (2021): $70K led by PPP
Key Investors in Dr Aharonov
PPP
Public-Private Partnership
What's next for Dr Aharonov?
With the infusion of this recent financing, Dr Aharonov is poised to enter a new phase of institutional growth. The strategic roadmap likely involves scaling the practice's infrastructure to accommodate increased patient demand while potentially integrating advanced medical technologies to enhance procedural outcomes. By focusing on operational efficiency and the expansion of its service portfolio, the firm aims to capture a larger share of the elective cosmetic surgery market. This late-stage funding context suggests a transition toward long-term sustainability and the potential for broader geographic or service-line diversification, ensuring the practice remains at the forefront of the facial plastic surgery industry.
See full Dr Aharonov company page
